Flu vaccine did not meet criteria for early success in late-stage trial: Moderna
Boston: Moderna Inc said on Tuesday its experimental flu vaccine did not meet the criteria for “early success” in a late-stage trial, and its shares fell 3%. The U.S. biotech company at its vaccine day meeting in Boston also said it expects to have six major vaccines on the market in the next few years. […] More